What Are Congenital Spine and Spinal Cord Disorders?
Congenital spine and spinal cord disorders are structural abnormalities that arise during the formation of the spine and nervous system as the baby develops in the womb. These disorders can be considered under the headings of spina bifida and spinal dysraphism.
Meningocele and myelomeningocele are among the best-known examples of this group. The type of disorder and the extent to which the spinal cord tissue is affected may influence the baby’s motor, sensory, bladder and bowel functions to varying degrees.
What Is the Difference Between Meningocele and Myelomeningocele?
In meningocele, the membranes surrounding the spinal cord, together with cerebrospinal fluid, protrude outward through the opening in the spine to form a sac. The sac usually does not contain spinal cord tissue.
In myelomeningocele, however, the spinal cord and neural tissue are also contained within this sac. For this reason, the risk of neurological involvement is generally more pronounced.
Particularly in open myelomeningocele lesions, early multidisciplinary follow-up and treatment are required to protect the neural tissue, reduce the risk of infection and evaluate associated problems.
What Problems Can Myelomeningocele Cause?
The effects of the condition vary according to the level of the lesion and the extent to which the spinal cord is affected. Weakness or sensory loss in the legs, walking difficulties, and bladder and bowel dysfunction may be seen.
Myelomeningocele may also be accompanied by problems related to the brain and nervous system, such as hydrocephalus and Chiari II malformation. Because bladder function may be affected, follow-up by pediatric urology and, when necessary, nephrology in addition to neurosurgery may be important.
Can Hydrocephalus Develop?
Yes. Hydrocephalus is a common problem in children with myelomeningocele. However, it does not present in the same way in every child, and it does not mean that every patient will require shunt treatment. The treatment decision is made by evaluating clinical findings and imaging results together.
How Is Treatment Planned?
Treatment is determined according to the type of the disorder and the baby’s clinical condition. In open myelomeningocele lesions, surgical closure after birth is an important treatment approach for protecting the neural tissue and reducing the risk of infection.
In some suitable patients, fetal surgery during pregnancy may also be considered. However, fetal surgery is not suitable for every patient, and the decision is made after a detailed evaluation at experienced centers.
After treatment, regular follow-up may be required for hydrocephalus, Chiari II malformation, tethered cord syndrome and bladder and bowel problems.
Can Congenital Spinal Cord Disorders Be Prevented?
Folate deficiency is an important and preventable risk factor for neural tube defects. In women planning a pregnancy, folic acid supplementation helps reduce the risk of neural tube defects. Nevertheless, because many genetic and environmental factors may play a role in the development of congenital spinal cord disorders, they cannot be attributed to a single cause.
Frequently Asked Questions
Can a child with myelomeningocele walk?
Walking potential varies according to the level of the lesion and the degree of spinal cord damage. Each child should be evaluated individually.
Does a meningocele always require surgery?
The treatment decision is made according to the characteristics of the lesion, its relationship with the spinal cord and the child’s clinical condition.
Does myelomeningocele heal completely?
Surgical treatment may help correct the existing structural problem and prevent new damage. However, complete recovery of nerve damage that has already occurred is not always possible.
Can myelomeningocele be detected during pregnancy?
Yes. It can be diagnosed during pregnancy with detailed ultrasonography and, where appropriate, fetal imaging methods.
Conclusion
In congenital spine and spinal cord disorders, early diagnosis, appropriate surgical planning and long-term multidisciplinary follow-up are important in preserving the child’s quality of life. Because the clinical features of each patient with meningocele or myelomeningocele differ, the treatment plan should be individualized.
References
- Rocque BG, Hopson BD, Blount JP. Caring for the Child with Spina Bifida. Pediatric Clinics of North America. 2021;68(4):915-927.
- Tortori-Donati P, Rossi A, Cama A. Spinal dysraphism: a review of neuroradiological features with embryological correlations and proposal for a new classification. Neuroradiology. 2000;42(7):471-491.
- Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. New England Journal of Medicine. 2011;364:993-1004.
- Centers for Disease Control and Prevention (CDC). Neural Tube Defects. 2025.
- Centers for Disease Control and Prevention (CDC). About Folic Acid. 2026.
- Kim I, Hopson B, Aban I, et al. Treated hydrocephalus in individuals with myelomeningocele in the National Spina Bifida Patient Registry. Journal of Neurosurgery: Pediatrics. 2018;22(6):646-651.
- Salih MA, Murshid WR, Seidahmed MZ. Classification, clinical features, and genetics of neural tube defects. Saudi Medical Journal. 2014;35(Suppl 1):S5-S14.